SerenQ Tirzepatide is a long-acting dual agonist peptide (GLP-1 + GIP) supplied in a sealed, pre-filled injection pen. No reconstitution, no bacteriostatic water, no drawing up from vials. Dial the units, read them off the window, dispense.
VLS Tirzepatide Prefilled Pen is a pharmaceutical-grade dual GLP-1/GIP receptor agonist in a convenient ready-to-use injection pen. Available in 20mg and 40mg variants, each VLS Tirzepatide pen delivers adjustable doses of 1, 2, 3, 4, or 5mg with included disposable needles. Lab verified 99.88% purity at 6.57mg/ml concentration. No mixing required.
Quanta Pharma Tirzepatide 30mg is a dual agonist peptide that activates both the GLP-1 and GIP receptors. It enhances insulin secretion and decreases glucagon levels, leading to improved glycemic control and weight loss. Lab verified 99.68% purity.
Quanta Pharma Tirzepatide 60mg is a dual agonist peptide that activates both the GLP-1 and GIP receptors. It enhances insulin secretion and decreases glucagon levels, leading to improved glycemic control and weight loss. Lab verified 99.90% purity.
